Destaca-te para esta função — gera um currículo e uma carta de apresentação personalizados em cerca de um minuto.
A MoonLake Immunotherapeutics procura um Especialista IT CSV para garantir que sistemas computarizados geridos pela IT, especialmente sistemas regidos por GxP, sejam validados, documentados e mantidos em conformidade com regulamentos da indústria.
O profissional irá reportar ao Head of IT e trabalhar na validação, documentação, auditorias e melhoria contínua, apoiando a prontidão para inspeções e a integridade de dados.
Empresa : Moonlake Tipo de Emprego : Periodo Integral Porto, Portugal
As a Specialist IT CSV, you will report to the Head of IT and play a critical role in ensuring that all IT-managed computerized systems - especially GxP-regulated and other critical systems (e.g., SOX, ISO27001) - are validated, documented, and maintained in compliance with applicable industry regulations and standards. Your work will support audit and inspection readiness, system and data integrity, and cross-functional collaboration across IT, Quality, and business teams. This is a dynamic opportunity for professionals who thrive in regulated environments and want to make a meaningful impact in biotech innovation.
An exciting job opportunity awaits you!
MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company unlocking the potential of sonelokimab, a novel investigational Nanobody® for the treatment of the inflammatory disease, to revolutionize outcomes for patients.
We continue to make significant progress in our Global Clinical Development Programs. The company’s focus is on inflammatory diseases with a major unmet need, including hidradenitis suppurativa and psoriatic arthritis – conditions affecting millions of people worldwide with a large need for improved treatment options. MoonLake was founded in 2021 and is headquarted in Zug, with hubs in Cambridge & Porto.
Further information is available at www.moonlaketx.com
Moonlake
MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company unlocking the potential of sonelokimab, a novel investigational Nanobody® for the treatment of the inflammatory disease, to revolutionize outcomes for patients. We continue to make significant progress in our Global Clinical Development Programs. The company’s focus is on inflammatory diseases with a major unmet need, including hidradenitis suppurativa and psoriatic arthritis – conditions affecting millions of people worldwide with a large need for improved treatment options. MoonLake was founded in 2021 and is headquarted in Zug, with hubs in Cambridge & Porto.
Ler mais sobre a empresa